The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.


Updates from The Motley Fool

Latest updates on Affymax, Inc. from Fool.com.


Stock Performance

AFFY vs. S&P 500 | 2 Year Performance
View Interactive AFFY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Affymax, Inc..
Current Price: $0.07
Prev Close: $0.07
Open: $0.07
Bid: $0.00
Ask: $0.00
Day's Range: $0.07 - $0.07
52wk Range: $0.06 - $0.11
Volume: 1,230
Avg Vol 13,318
Market Cap: $2.79M
P/E (ttm): 0.88
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Affymax, Inc..
CAPS Rating 2 out of 5
 
102 Outperform
36 Underperform
CAPS All Stars
 
8 Outperform
8 Underperform

How do you think Affymax, Inc. will perform against the market?



You pick for Affymax, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Affymax, Inc..

The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.

  • Exchange: NASDAQOTH
  • Sector: Healthcare
  • Industry: Drug Makers